FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23449 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Contusion,trunk NOS Contusion of trunk
ConvaTec two-piece ostomy system E Two-piece ostomy system
Convalescence NOS Convalescence
Convalescence NOS Convalescence
Conventional release chewable capsule Conventional release chewable soft capsule (dose form)
Conventional release intraocular solution Solution for injection
Conventional release intravesical or parenteral or urethral solution Powder for conventional release intravesical solution and solution for injection (dose form)
Conventional release pressurized suspension for nebulizer Conventional release suspension for nebulizer (dose form)
Conventional release solution for intraocular injection Solution for injection
Conventional release suspension for infusion Dispersion for infusion
Conventional release vapor capsule for inhalation Capsule for vapor inhalation
Conventional release vapor ointment for inhalation Ointment for vapour inhalation
Conventional release vapor powder for inhalation Conventional release powder for vapor inhalation (dose form)
Conventional release vapor solution for inhalation Solution for vapour inhalation
Conventional release vapor tablet for inhalation Tablet for vapour inhalation
Conversion from hemiarthroplasty of shoulder NEC Conversion from hemiarthroplasty of shoulder
Conversion from hybrid total knee replacement NEC Conversion from hybrid total knee replacement
Conversion from hybrid total prosthetic hip replacement NEC Conversion from hybrid total prosthetic hip replacement (procedure)
Conversion from hybrid total prosthetic hip replacement NEC Conversion from hybrid total prosthetic hip replacement (procedure)
Conversion from other type of arthroplasty Operation on joint arthroplasty (procedure)
Conversion from previous arthrodesis NEC Revision of arthrodesis
Conversion from previous hemiarthroplasty of hip NEC Revision of hip arthroplasty
Conversion from previous total prosthetic replacement of hip joint NEC Conversion from total prosthetic replacement of hip joint (procedure)
Conversion to arthrodesis NEC Revision of arthrodesis
Conversion to arthrodesis NOS Revision of arthrodesis
Conversion to total prosthetic replacement of hip joint NEC Conversion to total prosthetic replacement of hip joint (procedure)
Cook NOS Cook
Cook NOS Cook
Coombs test NOS Coombs test - anti-human globulin
Coombs test NOS Coombs test - anti-human globulin
Copper supplement Product containing copper (medicinal product)
Cord tangled with compression unspecified Entanglement and compression of umbilical cord (disorder)
Cord tangled with compression with antenatal problem Entanglement and compression of umbilical cord (disorder)
Cordylobia Cordylobia anthropophaga
Cormack and Lehane score Cormack and Lehane system (assessment scale)
Corn oil - dietary Corn oil (substance)
Cornea guttata Corneal guttata
Corneal anesthesia Corneal anesthesia (finding)
Corneal endotheliolitis Corneal endotheliitis
Corneal epithelial and basement membrane dystrophy Epithelial basement membrane dystrophy (disorder)
Corneal fragility keratoglobus, blue sclerae AND joint hypermobility A rare, hereditary connective tissue disease characterized by severe ocular manifestations due to extreme corneal thinning and fragility with rupture in the absence of significant trauma, often leading to irreversible blindness. Extraocular manifestations comprise deafness, developmental hip dysplasia, and joint hypermobility.
Coronary A by-pass anastam NOS Coronary artery bypass graft
Coronary A by-pass anastam NOS Coronary artery bypass graft
Coronary arteriog-general NOS Angiography of coronary artery (procedure)
Coronary arteriog-general NOS Angiography of coronary artery (procedure)
Coronary artery dissection Dissection of coronary artery (disorder)
Coronary artery operations NOS Operative procedure on coronary artery (procedure)
Coronary artery operations NOS Operative procedure on coronary artery (procedure)
Coronary heart disease risk clinical management plan Coronary heart disease risk clinical management plan
Coronary orifice atresia Congenital atresia of coronary ostium
Coronary vasodilator Vasodilator (substance)
Coronavirus Subfamily Orthocoronavirinae (organism)
Coronavirus as the cause of diseases classified to other chapters Coronavirus infection
Coronavirus as the cause of diseases classified to other chapters Coronavirus infection
Corpus luteum of pregnancy Corpus luteum of pregnancy
Corpus uteri TNM finding American Joint Committee on Cancer allowable value
Correction by appliance Appliance procedures
Correction by appliance Appliance procedures
Correction by appliance NOS Appliance procedures
Correction by appliance NOS Appliance procedures
Correction of atresia of external meatus of ear Meatoplasty of external ear
Correction of displacement of prosthesis NOC Attention to device (procedure)
Correction of tricuspid atresia Repair of tricuspid atresia
Corsodyl original mouthwash Product manufactured as oromucosal dose form (product)
Cortex contusion with open intracranial wound and unspecified state of consciousness Cortex contusion with open intracranial wound
Cortex contusion with open intracranial wound, with concussion, unspecified Contusion of cerebrum with open intracranial wound
Cortex contusion with open intracranial wound, with loss of consciousness of unspecified duration Contusion of cerebrum with open intracranial wound
Cortex contusion without mention of intracranial wound, with 1-24 hours loss of consciousness Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with less than 1 hour loss of consciousness Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with loss of consciousness of unspecified duration Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with more than 24 hours loss of consciousness and return to pre-existing conscious level Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with more than 24 hours loss of consciousness without return to pre-existing conscious level Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with no loss of consciousness Contusion of cerebral cortex
Cortex contusion without mention of open intracranial wound, with unspecified state of consciousness Contusion of cerebral cortex
Cortex contusion without open intracranial wound Contusion of cerebral cortex
Cortex contusion without open intracranial wound AND with concussion Contusion of cerebral cortex
Cortex contusion without open intracranial wound AND with loss of consciousness Contusion of cerebral cortex
Cortex contusion without open intracranial wound and with unspecified state of consciousness Contusion of cerebral cortex
Cortex laceration with open intracranial wound and unspecified state of consciousness Cortex laceration with open intracranial wound
Cortical dysplasia with focal epilepsy syndrome A rare genetic syndromic neurodevelopmental disorder with characteristics of moderate to mostly severe intellectual disability, speech impairment with normal or mildly delayed motor development and early-onset seizures often accompanied by developmental regression. Autistic behaviour and stereotypic movements are common. The disorder is caused by bi-allelic intragenic deletions (rarely duplications) or truncating variants in the CNTNAP2 gene (7q35-q36.1). It encodes contactin-associated protein 2 (CASPR2), a transmembrane protein from the neurexin superfamily, which is involved in neural-glia interactions and clustering of potassium channels in myelinated axons. Inheritance is autosomal recessive.
Corticosteroid binding globulin Corticotropin binding globulin
Corynebacterium flaccumfaciens Curtobacterium flaccumfaciens
Corynebacterium flaccumfaciens subsp betae Curtobacterium flaccumfaciens
Corynebacterium flaccumfaciens subsp oortii Curtobacterium flaccumfaciens
Corynebacterium flaccumfaciens subsp poinsettiae Curtobacterium flaccumfaciens
Corynebacterium liquefaciens Brevibacterium liquefaciens
Corynebacterium nigricans Corynebacterium aurimucosum (organism)
Corynebacterium paurometabolum Tsukamurella paurometabola (organism)
Corynebacterium vitarumen Corynebacterium vitaeruminis (organism)
Costing/accounting clerk NOS Costing/accounting clerk
Costing/accounting clerk NOS Costing/accounting clerk
Cough suppressants Antitussive agent (substance)
Counseled by person NOS Person counselled by
Counseling - general NOS Counseling procedure with explicit context (situation)
Counseling by other agency Person counselled by
Counseling for grieving NOS Grieving counselling
Counselled by person NOS Person counselled by
Counselling - general NOS Psychosocial procedure that involves listening, reflecting, etc. to facilitate recognition of course of action / solution.
Counselling by other agency Person counselled by
Count of active ingredient This attribute represents the number of active ingredients or precise active ingredients in a medicinal product. It is simply a count of attribute 'has active ingredient' or 'has precise active ingredient' in a concept definition.
Count of base and modification pair This attribute represents the number of different base and modification pairs in a medicinal product. If both bases and their modifications are the same, it is counted as 1 pair. The count is increased when the bases are the same but their modifications are different, for two or more pairs. Any further modification should not be counted as part of the pair.

Start Previous Page 44 of 235 Next End


Reference Sets

Reference set descriptor

Back to Start